Browse By: Country ι Category ι Latest Reports ι Tag

China Blood Product Industry Report, 2012-2015

Pages » 116
Published By » Research In China
Price » $2400
In stock
View Report Details
Description

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due to the implementation of favorable policies, widening gap between supply and demand, rising product prices and other factors, more than 150 plasma stations in China produced about 3,600 tons of plasma in 2012, up 14.2% year on year.  From 2012 to mid-2013, new plasma stations of some Chinese enterprises have started plasma collection or obtained plasma collection permits, such as Yuechi plasma station of Jiangxi Boya Bio-Pharmaceutical, Changyuan plasma station of Hualan Bio, and Caox... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research\'s report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufact
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Chinese Sovereign Wealth Fund Eyes Investment Opportunities in Australian Dairy Industry
China, which has been focusing on alternate industries in efforts to shift from traditional commodities such as iron, coal and ore, is showing interest in the Australian dairy industry. In its bid to safeguard supplies for its 1.3 billion people and provide them with secure and safe food resources, China has been investing more on agriculture industries. Australia’s agricultural sector which has been an investment focus of CIC (China Investment Corp.) is a high-tension sector and invest
Date: Sep 26

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency
Price: $4795